News of Note—U.K. research hub, Bavarian Nordic and more

newspaper
In this week's news of note, Bavarian Nordic named a new CFO. (Pixabay)

Here is some other vaccine news of note for the week.

> Officials in the U.K. outlined a plan for a vaccine research hub to help prevent and respond to outbreaks more effectively. Release

> Bavarian Nordic appointed Henrik Juuel, who has served at Novo Nordisk and Virgin Mobile, as its new CFO. Release

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> In an animal study, National Institute of Allergy and Infectious Diseases researchers reported that an HIV vaccine targeting a vulnerable site on the virus elicited antibodies against dozens of strains from around the world. Release

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.